HSP27-transgenic mice exhibit reduced infarcts after transient cerebral ischemia [18], and viral delivery of HSP27 and intraperitoneal injection of PEP1-HSP27, but not HSP27 recombinant protein, into ischemic animal models are also protective [19], [20]. This evidence concerns the gene HSPB1 and transient ischemic attack.